SCOPUS 정보 검색 플랫폼

Practical Gastroenterology

Volumn 31, Issue 2, 2007, Pages 72-76

The antibiotic rifaximin improves hepatic encephalopathy symptoms in patients with cirrhosis due to hepatitis C

(1) Palmer, Melissa a

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; ANTIBIOTIC AGENT; LACTULOSE; PEGINTERFERON; RIBAVIRIN; RIFAXIMIN;

ABDOMINAL PAIN; ADULT; AGED; AMMONIA BLOOD LEVEL; ANTIBIOTIC THERAPY; BLOATING; CLINICAL ARTICLE; DIARRHEA; DRUG TOLERABILITY; FEMALE; FLATULENCE; HEADACHE; HEPATIC ENCEPHALOPATHY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; HYPOGLYCEMIA; LIVER CIRRHOSIS; MALE; NAUSEA; NEPHROTOXICITY; OUTPATIENT; REVIEW; TREATMENT OUTCOME;

EID: 33847613264 PISSN: 02774208 EISSN: None Source Type: Journal
DOI: None Document Type: Review

Times cited : (2)

References (12)

1
- 0022469044
- The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis
- Gitlin N, Lewis DC, Hinkley L. The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis. J Hepatol, 1986; 3:75-82.
- (1986) J Hepatol , vol.3 , pp. 75-82
- Gitlin, N.¹ Lewis, D.C.² Hinkley, L.³

2
- 0018841822
- Psychomotor performance defects in cirrhotic patients without overt encephalopathy
- Gilberstadt SJ, Gilberstadt H, Zieve L, Buegel B, Collier RO Jr, McClain CJ. Psychomotor performance defects in cirrhotic patients without overt encephalopathy. Arch Intern Med, 1980; 140:519-521.
- (1980) Arch Intern Med , vol.140 , pp. 519-521
- Gilberstadt, S.J.¹ Gilberstadt, H.² Zieve, L.³ Buegel, B.⁴ Collier Jr, R.O.⁵ McClain, C.J.⁶

3
- 0035720629
- Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis
- Das A, Dhiman RK, Saraswat VA, Verma M, Naik SR. Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. J Gastroenterol Hepatol, 2001; 16:531-535.
- (2001) J Gastroenterol Hepatol , vol.16 , pp. 531-535
- Das, A.¹ Dhiman, R.K.² Saraswat, V.A.³ Verma, M.⁴ Naik, S.R.⁵

4
- 0034944406
- Hepatic encephalopathy
- Blei AT, Cordoba J. Hepatic encephalopathy. Am J Gastroenterol, 2001; 96:1968-1976.
- (2001) Am J Gastroenterol , vol.96 , pp. 1968-1976
- Blei, A.T.¹ Cordoba, J.²

5
- 0018834126
- Hypernatremia in hepatic failure
- Warren SE, Mitas JA II, Swerdlin AH. Hypernatremia in hepatic failure. JAMA, 1980; 243:1257-1260.
- (1980) JAMA , vol.243 , pp. 1257-1260
- Warren, S.E.¹ Mitas II, J.A.² Swerdlin, A.H.³

6
- 20544461377
- Rifaximin, a nonabsorbed oral antibiotic, in the treatment of hepatic encephalopathy: Antimicrobial activity, efficacy, and safety
- Williams R, Bass N. Rifaximin, a nonabsorbed oral antibiotic, in the treatment of hepatic encephalopathy: Antimicrobial activity, efficacy, and safety. Rev Gastroenterol Disord, 2005; 5 suppl 1:10-18.
- (2005) Rev Gastroenterol Disord , vol.5 , Issue.SUPPL. 1 , pp. 10-18
- Williams, R.¹ Bass, N.²

7
- 0017889855
- Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial
- Atterbury CE, Maddrey WC, Conn HO. Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial. Am J Dig Dis. 1978; 23:398-406.
- (1978) Am J Dig Dis , vol.23 , pp. 398-406
- Atterbury, C.E.¹ Maddrey, W.C.² Conn, H.O.³

8
- 23344446406
- Researchers investigate factors linked to development of secondary diabetes
- Trubo R. Researchers investigate factors linked to development of secondary diabetes. JAMA, 2005; 294:668-670.
- (2005) JAMA , vol.294 , pp. 668-670
- Trubo, R.¹

9
- 0028969169
- Marked deterioration in glycemic control with change in brand of lactulose syrup
- Kirkman MS, Zimmerman DR, Filippini SA. Marked deterioration in glycemic control with change in brand of lactulose syrup. South Med J, 1995; 88:492-493.
- (1995) South Med J , vol.88 , pp. 492-493
- Kirkman, M.S.¹ Zimmerman, D.R.² Filippini, S.A.³

10
- 13744254182
- Chronic hepatitis C and type II diabetes mellitus: A prospective cross-sectional study
- Zein CO, Levy C, Basu A, Zein NN. Chronic hepatitis C and type II diabetes mellitus: A prospective cross-sectional study. Am J Gastroenterol, 2005; 100:48-55.
- (2005) Am J Gastroenterol , vol.100 , pp. 48-55
- Zein, C.O.¹ Levy, C.² Basu, A.³ Zein, N.N.⁴

11
- 33745566007
- Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis
- Sigal SH, Stanca CM, Kontorinis N, Bodian C, Ryan E. Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis. Am J Gastroenterol, 2006; 101:1490-1496.
- (2006) Am J Gastroenterol , vol.101 , pp. 1490-1496
- Sigal, S.H.¹ Stanca, C.M.² Kontorinis, N.³ Bodian, C.⁴ Ryan, E.⁵

12
- 2942557181
- Peginterferon-alpha(2b) and ribavirin
- Ahn J, Flamm S. Peginterferon-alpha(2b) and ribavirin. Expert Rev Anti Infect Ther, 2004; 2:17-25.
- (2004) Expert Rev Anti Infect Ther , vol.2 , pp. 17-25
- Ahn, J.¹ Flamm, S.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.